KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Total Liabilities: 2010-2024

Historic Total Liabilities for TherapeuticsMD (TXMD) over the last 14 years, with Dec 2024 value amounting to $11.5 million.

  • TherapeuticsMD's Total Liabilities fell 9.88% to $11.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.2 million, marking a year-over-year decrease of 9.88%. This contributed to the annual value of $11.5 million for FY2024, which is 18.33% down from last year.
  • As of FY2024, TherapeuticsMD's Total Liabilities stood at $11.5 million, which was down 18.33% from $14.0 million recorded in FY2023.
  • TherapeuticsMD's 5-year Total Liabilities high stood at $305.6 million for FY2020, and its period low was $11.5 million during FY2024.
  • Its 3-year average for Total Liabilities is $26.9 million, with a median of $14.0 million in 2023.
  • Its Total Liabilities has fluctuated over the past 5 years, first grew by 19.01% in 2020, then tumbled by 78.98% in 2022.
  • TherapeuticsMD's Total Liabilities (Yearly) stood at $305.6 million in 2020, then dropped by 13.91% to $263.1 million in 2021, then plummeted by 78.98% to $55.3 million in 2022, then crashed by 74.65% to $14.0 million in 2023, then fell by 18.33% to $11.5 million in 2024.